2025 Year in Review

In 2025, HRSA advanced its mission to improve health outcomes and strengthen access to care nationwide. Through streamlined operations and targeted initiatives, we delivered measurable results that align with federal priorities and reinforce our commitment to serving communities effectively. These efforts reflect our dedication to supporting the Trump Administration’s objectives for efficiency, accountability, and impact across health programs.
 
 

Strengthened national health outcomes under the Make America Healthy Again (MAHA) Initiative

• HRSA-supported health centers:
  • Served 32.4 million patients, including 1.1 million new patients—the largest increase in 3 years.
  • Served 1 in 8 children, adding nearly 300,000 more pediatric patients—a 3% increase since 2023.
  • Provided preventive screenings to more than 10 million patients—a 6% increase—with notable gains in colorectal, breast, and cervical cancer screenings.
  • Screened more than 222,250 children for weight assessments and nutrition counseling—a 5% increase.
  • Expanded telehealth by providing 17.6 million virtual visits—representing 13% of all patient visits and 37% of all mental health visits. This included nearly 107,000 more virtual visits and over 95,000 more mental health visits since 2023.
• The National Maternal Mental Health Hotline expanded access to 24/7 perinatal mental health support. In 2025, the Hotline received more than 30,000 calls and texts—a 35% increase from the previous year—including a record 3,800 calls and texts in August.
• Nearly 602,000 people with HIV were provided with health care and support services through the Ryan White HIV/AIDS Program. Patients in the program achieved a 91.4% viral suppression rate—well above national benchmarks.
• Through the support of Secretary Kennedy, we approved adding Duchenne Muscular Dystrophy (DMD) and Metachromatic Leukodystrophy (MLD) to the Recommended Uniform Screening Panel (RUSP) following scientific review and public comment. Finding these conditions early helps children get FDA-approved treatments at the right time. Early treatment can slow the disease and help children maintain a better quality of life.
• Working with the Administration for Children and Families, we released the Mother and Infant Home Visiting Program Evaluation (MIHOPE) study. It found that the Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Program has long-term, positive effects on the health and well-being of mothers and families. In 2025, the MIECHV Program served all 50 states, the District of Columbia, and 5 U.S. territories, and provided over 1 million home visits.
• More than 522,750 people were served through rural health programs, significantly expanding access to rural communities.
• The HHS Telehealth Hub was expanded to include a patient tip sheet (PDF - 157 KB) and provider best practice guide on using telehealth for nutrition care. The information highlights how telehealth helps people of all ages get personalized nutrition care and services from home.

Lowered costs & protected patients

• We approved recommendations to update the Women’s Preventive Services Guidelines related to cervical cancer screening—one of the most effective ways to detect precancerous changes and early-stage cancers.
• We took steps that received national attention and advanced efforts to lower out-of-pocket costs for life-saving medications. HRSA-supported health centers must now offer insulin and injectable epinephrine to low-income patients at or below the 340B Program’s purchase price.
• In 2024, grantees and hospitals in the 340B Program purchased $81.4 billion in covered outpatient medications—a 23% increase from the previous year.

Expanded the modernization of the national organ transplantation system

Over the past year, we:

• Supported nearly 48,600 solid organ transplants—the highest number ever recorded—and facilitated ongoing modernization of the Organ Procurement and Transplantation Network.
• Announced a new 34-member Board of Directors through a special election. Voter turnout reflected strong engagement from the OPTN community, with an 83% participation rate in the national election—a big increase from the 68% average turnout during the Biden Administration.
• Secured user fee authority to sustain long-term transplant system modernization.
• Strengthened oversight through corrective action plans, targeted investigations, and coordination with partner agencies. We moved whistleblower reporting to HRSA, which led to more patient safety reports and faster oversight and improvements. We also decertified a major organ procurement organization after finding years of unsafe practices, poor training, chronic underperformance, understaffing, and paperwork errors.
• Deployed AI tools to improve financial oversight, data quality, audit readiness, and cybersecurity compliance. We launched a public “allocation out of sequence” (AOOS) dashboard to track when organ donations or transplants happen outside the standard list of matched patients. This helps HHS identify noncompliance and gives patients, families, and clinicians clear information about whether the system is operating fairly.

Strengthened the health workforce

Last year, we:

• Supported more than 5,540 trainees and added over 3,500 graduates through HRSA workforce programs, with nearly 22,570 clinicians serving in underserved communities nationwide.
• Created 60 new accredited rural residency programs since 2019 to strengthen long-term rural workforce capacity.
• Expanded behavioral health and substance use response services, including adding 425 new behavioral health providers in rural areas and distributing naloxone at about 95% of Rural Communities Opioid Response Program sites.

Increased stakeholder outreach and engagement

In 2025, we:

• Held more than 300 outreach events, reached more than 6,000 webinar participants, delivered over two dozen congressional briefings, led national public awareness campaigns, presented at national conferences, and hosted roundtables and convenings.
• Testified at two subcommittee hearings of the House Energy and Commerce Committee—one on oversight of the U.S. organ procurement and transplant system and one on health care workforce legislation.
• Implemented a targeted Tribal Advisory Council (TAC) recruitment campaign, achieving 92% seat occupancy and filling 11 of 12 delegate positions. The TAC will advise HRSA on emerging public health issues in Indian Country and collaborative approaches to help American Indian/Alaska Native populations.
• Presented at major tribal conferences and meetings to increase awareness of HRSA programs among more than 2,000 tribal leaders, health officials, and tribal citizens.

Download a PDF version (PDF - 121 KB)